Week In Review: Cellular Biomedicine In-licenses Cancer Immunotherapy From China By: TalkMarkets February 15, 2015 at 10:44 AM EST Deals, trials, financings and approvals in China healthcare sector this week. Read More >> Related Stocks: Abliva Ab Cellular Biomedicine Merck & Co Novo Nordisk A/S ADR Sihuan Pharmaceutical Holdings Group Ltd